ANNA O’KEEFFE

RESEARCH SCIENTIST

anna.o’keeffe@nyulangone.org

Anna grew up in Dublin, Ireland, where she obtained her Bachelor of Science in Pharmacology at University College Dublin. She worked under Dr. Antoinette Perry during her undergraduate studies, studying anti-cancer and chemoprevention properties of marine plant bioactives. 

She moved to New York City and joined NYU Langone in 2019 as a research associate in the lab of Dr. Victor Torres. Her work focused on the development of a vaccine against Staphylococcus aureus infections and studying the pathogenesis of multi-drug resistant bacteria.

Anna is excited to join the Neuroscience Institute and to learn from this talented team!

KEY PUBLICATIONS

1. Poolman JT, Torres VJ, Missiakas D, Welten SPM, Fernandez J, DuMont AL, O'Keeffe A, Konstantinov SR, Morrow B, Burghout P, Grijpstra J, van Beers MMC, Anish C, Beurret M, Geurtsen J, Rood PML, Koeberling O, Shi M, van den Dobbelsteen GPJM (2025) A SpA+LukAB vaccine targeting Staphylococcus aureus evasion factors restricts infection in two minipig infection models. NPJ Vaccines 10(1):78. doi: 10.1038/s41541-025-01119-8. PMID: 40254611.

2. Lubkin A, Bernard-Raichon L, DuMont AL, Valero Jimenez AM, Putzel GG, Gago J, Zwack EE, Olusanya O, Boguslawski KM, Dallari S, Dyzenhaus S, Herrmann C, Ilmain JK, Isom GL, Pawline M, Perault AI, Perelman S, Sause WE, Shahi I, St John A, Tierce R, Zheng X, Zhou C, Noval MG, O'Keeffe A, Podkowik M, Gonzales S, Inglima K, Desvignes L, Hochman SE, Stapleford KA, Thorpe LE, Pironti A, Shopsin B, Cadwell K, Dittmann M, Torres (2024) SARS-CoV-2 infection predisposes patients to coinfection with Staphylococcus aureus. VJ.mBio. 15(8):e0166724. PMID: 39037272.